MoneyWorks4Me

Medico Remedies - Quaterly Results

12 Nov 2022 Evaluate
The sales moved up 36.99% to Rs. 404.62 millions for the September 2022 quarter as compared to Rs. 295.37 millions during the year-ago period.Profit for the quarter ended September 2022 rises by 71.22% to Rs. 28.68  millions from Rs. 16.75 millions.Operating profit surged to 46.97 millions from the corresponding previous quarter of 29.63 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 404.62 295.37 36.99 736.00 586.12 25.57 1210.21 1223.86 -1.12
Other Income 15.50 8.03 93.03 31.46 10.61 196.51 20.29 10.31 96.80
PBIDT 46.97 29.63 58.52 61.08 38.36 59.23 92.37 62.59 47.58
Interest 1.74 1.66 4.82 3.41 3.29 3.65 6.08 9.22 -34.06
PBDT 45.23 27.97 61.71 57.67 35.07 64.44 86.29 53.37 61.68
Depreciation 6.64 4.70 41.28 12.57 9.02 39.36 20.80 16.52 25.91
PBT 38.59 23.27 65.84 45.10 26.05 73.13 65.49 36.85 77.72
TAX 9.91 6.52 51.99 12.85 7.89 62.86 16.60 10.94 51.74
Deferred Tax 1.66 -0.18 -1022.22 2.87 0.29 889.66 -1.34 -0.56 139.29
PAT 28.68 16.75 71.22 32.25 18.16 77.59 48.89 25.91 88.69
Equity 165.97 165.97 0.00 165.97 165.97 0.00 165.97 41.49 300.02
PBIDTM(%) 11.61 10.03 15.72 8.30 6.54 26.80 7.63 5.11 49.24
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..